Publications by authors named "Kenji Kitazato"

Claim this Profile
N
Novel iontophoretic administration method for local therapy of breast cancer.
Masahito Komuro, Kenichi Suzuki, Makoto Kanebako, Takashi Kawahara, Takeshige Otoi, Kenji Kitazato

J Control Release· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preparation and properties of inhalable nanocomposite particles for treatment of lung cancer.
Keishiro Tomoda, Takumi Ohkoshi, Keiji Hirota, Ganeshchandra S Sonavane, Takehisa Nakajima, Kenji Kitazato

Colloids Surf B Biointerfaces· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A synthetic retinoid, TAC-101 (4-[3,5-bis (trimethylsilyl) benzamido] benzoic acid), plus cisplatin: potential new therapy for ovarian clear cell adenocarcinoma.
Sachiko Ezawa, Nao Suzuki, Shinji Ohie, Atsushi Higashiguchi, Fumihito Hosoi, Kenji Kitazato

Gynecol Oncol· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Excess HDM2 impacts cell cycle and apoptosis and has a selective effect on p53-dependent transcription.
Shuichi Ohkubo, Tomoaki Tanaka, Yoichi Taya, Kenji Kitazato, Carol Prives

J Biol Chem· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene expression analysis using human cancer xenografts to identify novel predictive marker genes for the efficacy of 5-fluorouracil-based drugs.
Akio Ooyama, Teiji Takechi, Etsuko Toda, Hideki Nagase, Yoshihiro Okayama, Kenji Kitazato

Cancer Sci· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlations between antitumor activities of fluoropyrimidines and DPD activity in lung tumor xenografts.
Teiji Takechi, Hiroyuki Okabe, Kazumasa Ikeda, Akio Fujioka, Fumio Nakagawa, Kenji Kitazato

Oncol Rep· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Napthalimidobenzamide DB-51630: a novel DNA binding agent inducing p300 gene expression and exerting a potent anti-cancer activity.
Kenji Suzuki, Hideko Nagasawa, Yoshihiro Uto, Yoshikazu Sugimoto, Kazuharu Noguchi, Kenji Kitazato

Bioorg Med Chem· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antimetastatic and anticancer activity of S-1, a new oral dihydropyrimidine-dehydrogenase-inhibiting fluoropyrimidine, alone and in combination with paclitaxel in an orthotopically implanted human breast cancer model.
Mamoru Nukatsuka, Akio Fujioka, Fumio Nakagawa, Hideyuki Oshimo, Kenji Kitazato

Int J Oncol· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel anticancer ribonucleoside, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine, enhances radiation-induced cell death in tumor cells.
Osamu Inanami, Daisuke Iizuka, Akiko Iwahara, Tohru Yamamori, Yasuhiro Kon, Kenji Kitazato

Radiat Res· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel retinoid, 4-[3,5-bis (trimethylsilyl) benzamido] benzoic acid (TAC-101), induces apoptosis of human ovarian carcinoma cells and shows potential as a new antitumor agent for clear cell adenocarcinoma.
Nao Suzuki, Daisuke Aoki, Shinji Oie, Miwa Horiuchi, Yuko Hasegawa, Kenji Kitazato

Gynecol Oncol· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged bleeding time induced by anticoagulant glycosaminoglycans in dogs is associated with the inhibition of thrombin-induced platelet aggregation.
Kenji Kitazato, Keiko T Kitazato, Eiji Sasaki, Kazuhisa Minamiguchi, Hideki Nagase

Thromb Res· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel antimetabolite, TAS-102 retains its effect on FU-related resistant cancer cells.
Tomohiro Emura, Yuko Murakami, Fumio Nakagawa, Masakazu Fukushima, Kenji Kitazato

Int J Mol Med· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thymidine kinase and thymidine phosphorylase level as the main predictive parameter for sensitivity to TAS-102 in a mouse model.
Tomohiro Emura, Fumio Nakagawa, Akio Fujioka, Hideyuki Ohshimo, Kenji Kitazato

Oncol Rep· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An optimal dosing schedule for a novel combination antimetabolite, TAS-102, based on its intracellular metabolism and its incorporation into DNA.
Tomohiro Emura, Fumio Nakagawa, Akio Fujioka, Hideyuki Ohshimo, Tatsushi Yokogawa, Kenji Kitazato

Int J Mol Med· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrin-linked kinase regulates vascular morphogenesis induced by vascular endothelial growth factor.
Yayoi Kaneko, Kenji Kitazato, Yuji Basaki

J Cell Sci· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Both N- and C-terminal transactivation functions of DNA-bound ERalpha are blocked by a novel synthetic estrogen ligand.
Yasuji Yamamoto, Osamu Wada, Ichiro Takada, Yoshiko Yogiashi, Jiro Shibata, Kenji Kitazato

Biochem Biophys Res Commun· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Depolymerized holothurian glycosaminoglycan (DHG), a novel alternative anticoagulant for hemodialysis, is safe and effective in a dog renal failure model.
Kazuhisa Minamiguchi, Keiko T Kitazato, Hideki Nagase, Eiji Sasaki, Katsuo Ohwada, Kenji Kitazato

Kidney Int· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance of UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-3 (GalNAc-T3) expression in patients with gastric carcinoma.
Koji Onitsuka, Kazunori Shibao, Yoshifumi Nakayama, Noritaka Minagawa, Keiji Hirata, Kenji Kitazato

Cancer Sci· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[The antitumor activity of DPD inhibitory-fluoropyrimidine (DIF) and non-DIF alone or in combination with paclitaxel against orthotopically implanted human breast cancer].
Mamoru Nukatsuka, Akio Fujioka, Fumio Nakagawa, Hideyuki Ohshimo, Kenji Kitazato

Gan To Kagaku Ryoho· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of UDP-N-acetyl-alpha-D-galactosamine-polypeptide galNAc N-acetylgalactosaminyl transferase-3 in relation to differentiation and prognosis in patients with colorectal carcinoma.
Kazunori Shibao, Hiroto Izumi, Yoshifumi Nakayama, Ryo Ohta, Naoki Nagata, Kenji Kitazato

Cancer· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Gamma-hydroxybutyric acid, a metabolite of UFT, shows anti-angiogenic activities and antitumor effect].
Yuji Basaki, Kazutaka Miyadera, Kazuhiko Yonekura, Kumio Aoyagi, Lumi Chikahisa, Kenji Kitazato

Gan To Kagaku Ryoho· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis